Clinical Trial Update: Salvage Therapy With Bevacizumab Plus Docetaxel and Cisplatin for Taiwanese Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 salvage-therapy trial in Taiwanese patients with metastatic breast cancer evaluating the combination of bevacizumab, docetaxel, and cisplatin has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Taipei Medical University Hospital | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED